Skip to main content

Peer Review reports

From: A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

Original Submission
14 Jun 2012 Submitted Original manuscript
29 Aug 2012 Reviewed Reviewer Report - jason chesney
29 Sep 2012 Reviewed Reviewer Report - Michael Morse
19 Oct 2012 Reviewed Reviewer Report - Mayer Fishman
21 Dec 2012 Author responded Author comments - Joseph Connor
Resubmission - Version 2
21 Dec 2012 Submitted Manuscript version 2
Publishing
11 Jan 2013 Editorially accepted
15 Jan 2013 Article published 10.1186/1471-2407-13-20

You can find further information about peer review here.

Back to article page